LUIS OLIVERA-RODRIGUEZ: Open Payments
NPI 1487919932 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,726 in 198 payments from 20 companies in 2025. Trend: 2023 $6,219 · 2024 $5,643 · 2025 $5,726
Food & beverage: $5,654Education: $71
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $802 |
| Axsome Therapeutics, Inc. | 20 | $707 |
| Otsuka America Pharmaceutical, Inc. | 19 | $497 |
| Neurocrine BioSciences, Inc. | 15 | $494 |
| Alkermes, Inc. | 13 | $487 |
| ABBVIE INC. | 16 | $466 |
| E.R. Squibb & Sons, L.L.C. | 12 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $296 |
| Corium, LLC | 14 | $288 |
| Janssen Pharmaceuticals, Inc | 9 | $284 |
Products named: CAPLYTA, REXULTI, Auvelity, INGREZZA, COBENFY, VRAYLAR, TRINTELLIX, Azstarys.
Industry payments across FL — which companies pay providers there.
